Drug · DIN 01919458
CYTOMEL
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since March 20, 2013; first marketed December 31, 1993.
- Drug Identification Number (DIN)
- 01919458
- Company (DIN owner)
- Pfizer Canada UlcKirkland, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Liothyronine sodium H03AA02
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| LIOTHYRONINE (LIOTHYRONINE SODIUM) | 5 MCG |
Notices of Compliance
Health Canada approvals that name this DIN.
- August 12, 2011: NOC 12553New Drug Submission (NDS) · Manufacturer Name Change
- April 24, 2007: NOC 8734New Drug Submission (NDS) · Manufacturer name change
Other DINs named CYTOMEL
- DIN 01919466 · Marketed